Current perspectives on KMT2A fusion proteins and menin inhibition in paediatric acute myeloid leukaemia

Documenti analoghi

• The AXL inhibitor bemcentinib overcomes microenvironment‐mediated resistance to pioglitazone in acute myeloid leukemia
  di: Jaja Zhu, et al.
  Pubblicazione: (2024)
• The deubiquitinating enzyme USP 8 promotes tyrosine kinase inhibitors resistance in chronic myeloid leukemia by stabilizing EIF 2 S 1 protein
  di: Shan Zhang, et al.
  Pubblicazione: (2025)
• Age‐associated myeloid malignancies – the role of STAT3 and STAT5 in myelodysplastic syndrome and acute myeloid leukemia
  di: Eirini Sofia Fasouli, et al.
  Pubblicazione: (2024)
• Pentraxin‐related protein PTX3 alleviates blast‐induced acute lung injury by promoting efferocytosis to eliminate ferroptotic alveolar epithelial cells in vitro
  di: Chang‐Mei Weng, et al.
  Pubblicazione: (2025)
• Nemo‐like kinase blocks myeloid differentiation by targeting tumor suppressor C/EBPα in AML
  di: Anil Kumar Singh, et al.
  Pubblicazione: (2024)